- Home
- BCRX vs RHI Comparison
BCRX vs RHI Comparison
Compare BCRX & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | RHI |
|---|---|---|
| Founded | 1986 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | 1995 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BCRX | RHI |
|---|---|---|
| Price | $8.26 | $27.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 7 |
| Target Price | $20.82 | ★ $30.33 |
| AVG Volume (30 Days) | ★ 4.2M | 2.1M |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 8.68% |
| EPS Growth | ★ 381.40 | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | $25,186,000.00 | ★ $5,378,506,000.00 |
| Revenue This Year | N/A | $1.27 |
| Revenue Next Year | $12.55 | $5.95 |
| P/E Ratio | ★ N/A | $195.43 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.00 | $21.83 |
| 52 Week High | $11.31 | $46.69 |
Technical Indicators
Market Signals| Indicator | BCRX | RHI |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 54.71 |
| Support Level | $7.94 | $25.93 |
| Resistance Level | $8.68 | $28.28 |
| Average True Range (ATR) | 0.46 | 1.41 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 23.34 | 80.88 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About RHI Robert Half Inc.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry.